AZEREDO DA SILVEIRA LAJAUNIAS, Samareh,LAJAUNIAS, Frédéric
申请号：
LT17731852
公开号：
LT3471732T
申请日:
2017.06.15
申请国别(地区):
LT
年份:
2020
代理人:
摘要：
The present invention relates to a composition comprising, preferably consisting of, (i) a single empty liposome, wherein said single empty liposome is selected from (a) an empty liposome consisting of sphingomyelin and cholesterol, wherein the amount of cholesterol is at least 20% (weight per weight)； or (b) an empty liposome consisting of sphingomyelin； or (ii) a mixture of empty liposomes； wherein said mixture of empty liposomes comprises (a) a first empty liposome consisting of sphingomyelin and cholesterol, wherein the amount of cholesterol is at least 20% (weight per weight)； and (b) a second empty liposome consisting of sphingomyelin； for use in a method of treating or preventing a viral infection in a mammal, preferably in a human.
